Amalgamated Bank’s Apellis Pharmaceuticals APLS Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $140K | Buy |
8,111
+866
| +12% | +$14.9K | ﹤0.01% | 1639 |
|
2025
Q1 | $158K | Buy |
7,245
+291
| +4% | +$6.35K | ﹤0.01% | 1587 |
|
2024
Q4 | $222K | Sell |
6,954
-41
| -0.6% | -$1.31K | ﹤0.01% | 1549 |
|
2024
Q3 | $202K | Hold |
6,995
| – | – | ﹤0.01% | 1580 |
|
2024
Q2 | $268K | Buy |
6,995
+359
| +5% | +$13.8K | ﹤0.01% | 1501 |
|
2024
Q1 | $390K | Sell |
6,636
-13,821
| -68% | -$812K | ﹤0.01% | 1404 |
|
2023
Q4 | $1.23M | Sell |
20,457
-1,728
| -8% | -$103K | 0.01% | 1083 |
|
2023
Q3 | $844K | Buy |
22,185
+763
| +4% | +$29K | 0.01% | 1183 |
|
2023
Q2 | $1.95M | Buy |
21,422
+8,128
| +61% | +$741K | 0.02% | 897 |
|
2023
Q1 | $877K | Sell |
13,294
-2,109
| -14% | -$139K | 0.01% | 1161 |
|
2022
Q4 | $796K | Buy |
15,403
+231
| +2% | +$11.9K | 0.01% | 1243 |
|
2022
Q3 | $1.04M | Buy |
15,172
+772
| +5% | +$52.7K | 0.01% | 1093 |
|
2022
Q2 | $651K | Buy |
14,400
+1,936
| +16% | +$87.5K | 0.01% | 1337 |
|
2022
Q1 | $633K | Sell |
12,464
-87
| -0.7% | -$4.42K | ﹤0.01% | 1449 |
|
2021
Q4 | $593K | Buy |
12,551
+997
| +9% | +$47.1K | ﹤0.01% | 1498 |
|
2021
Q3 | $381K | Sell |
11,554
-711
| -6% | -$23.4K | ﹤0.01% | 1723 |
|
2021
Q2 | $775K | Buy |
12,265
+3,715
| +43% | +$235K | 0.01% | 1409 |
|
2021
Q1 | $367K | Sell |
8,550
-833
| -9% | -$35.8K | 0.01% | 1146 |
|
2020
Q4 | $537K | Buy |
9,383
+51
| +0.5% | +$2.92K | 0.02% | 925 |
|
2020
Q3 | $282K | Sell |
9,332
-282
| -3% | -$8.52K | 0.01% | 1139 |
|
2020
Q2 | $314K | Buy |
9,614
+127
| +1% | +$4.15K | 0.01% | 1083 |
|
2020
Q1 | $254K | Buy |
9,487
+748
| +9% | +$20K | 0.01% | 1228 |
|
2019
Q4 | $268K | Buy |
8,739
+162
| +2% | +$4.97K | ﹤0.01% | 1475 |
|
2019
Q3 | $207K | Sell |
8,577
-80
| -0.9% | -$1.93K | ﹤0.01% | 1527 |
|
2019
Q2 | $219K | Buy |
+8,657
| New | +$219K | 0.01% | 1533 |
|